ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

SGP vs KIDS // RSI-14 & 200D SMA MOMENTUM

SpyGlass Pharma Inc. (NASDAQ) VS. OrthoPediatrics Corp. (NASDAQ) • 15-METRIC TALLY: SGP 1 — KIDS 4
▲ RSI-14 & 200D SMA MOMENTUM LEADER: KIDS
rsi-technicals
77.8
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SGP VS. KIDS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC SGP KIDS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 73.10% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -7.30% -27.70 KIDS /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -3.08% -1.94% -1.14 KIDS /fcf-yield <GO>
Operating Margin — -16.60% — TIE /operating-margins <GO>
Net Profit Margin — -16.80% — TIE /net-margins <GO>
Revenue Growth (YoY) — 15.40% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 3.00 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 5/9 -3.00 KIDS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum ACTIVE 71.4 77.8 -6.42 KIDS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.09B $823.0M $264.4M SGP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR SGP REV KIDS REV SGP GROSS % KIDS GROSS % SGP FCF KIDS FCF
FY 2025 $0 $236.3M — 73.1% -$33.5M -$16.0M
FY 2024 $0 $204.7M — 72.6% -$24.0M -$41.3M
FY 2023 — $148.7M — — — -$27.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SGP // BETA —
KIDS // BETA —